PAINWeek 2012: Acute Pain

PAINWeek 2012: Acute Pain

Adding SSRIs or SNRIs to Tapentadol Does Not Increase Adverse Events

Vincent Brett, MS, PharmD, of Janssen Scientific Affairs, Raritan, NJ, and colleagues presented a post-hoc analysis of pooled safety data at PAINWeek 2012, and found that adding tapentadol to selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) resulted in no clinically relevant adverse drug interactions.